We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.65%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$260B
AUM Growth
+$14.3B
(+5.8%)
Cap. Flow
-$9.91B
Cap. Flow
% of AUM
-3.81%
Top 10 Holdings %
Top 10 Hldgs %
22.61%
Holding
3,378
New
92
Increased
1,419
Reduced
1,604
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$292M |
| 2 |
Merck
MRK
|
+$239M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$232M |
| 4 |
Intuitive Surgical
ISRG
|
+$225M |
| 5 |
Walmart Inc
WMT
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.01B |
| 2 |
Apple
AAPL
|
+$979M |
| 3 |
PPLI
People Inc
PPLI
|
+$793M |
| 4 |
Tesla
TSLA
|
+$671M |
| 5 |
Microsoft
MSFT
|
+$654M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.21% |
| 2 | Healthcare | 13.86% |
| 3 | Consumer Discretionary | 13.19% |
| 4 | Financials | 11.5% |
| 5 | Communication Services | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Weyco Group
WEYS
$440M
| $384K | ﹤0.01% |
23,734
+288
| +1% | +$5.26K |
|
|
DZSI
3002
DELISTED
DZS Inc. Common Stock
DZSI
| $384K | ﹤0.01% |
41,056
+17,530
| +75% | +$176K |
|
|
CDTX
3003
DELISTED
Cidara Therapeutics
CDTX
| $382K | ﹤0.01% |
6,697
-1,448
| -18% | -$102K |
|
|
NYMX
3004
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $382K | ﹤0.01% |
155,495
-18
| -0% | -$52 |
|
3005
Crawford & Co Class A
CRD.A
$669M
| $380K | ﹤0.01% |
58,020
+12,330
| +27% | +$91.2K |
|
3006
Arq
ARQ
$89.3M
| $380K | ﹤0.01% |
93,599
+30,187
| +48% | +$129K |
|
3007
HBT Financial
HBT
$1.32B
| $377K | ﹤0.01% |
33,669
-4,595
| -12% | -$56.2K |
|
|
STEX
3008
Streamex Corp
STEX
$83M
| $375K | ﹤0.01% |
7,610
+846
| +13% | +$62.7K |
|
3009
BCB Bancorp
BCBP
$161M
| $373K | ﹤0.01% |
46,610
-28
| -0.1% | -$234 |
|
|
EEX
3010
DELISTED
Emerald Holding
EEX
| $373K | ﹤0.01% |
183,006
-34,424
| -16% | -$91.1K |
|
3011
Lifetime Brands
LCUT
$211M
| $372K | ﹤0.01% |
39,402
-55
| -0.1% | -$473 |
|
|
RVLP
3012
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $368K | ﹤0.01% |
68,015
+45,115
| +197% | +$260K |
|
|
JHG
3013
DELISTED
Janus Henderson
JHG
| $366K | ﹤0.01% |
16,844
+1,601
| +11% | +$33.2K |
|
|
AVEO
3014
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $366K | ﹤0.01% |
61,636
+27,656
| +81% | +$137K |
|
|
ESSA
3015
DELISTED
ESSA Bancorp
ESSA
| $365K | ﹤0.01% |
29,540
+139
| +0.5% | +$1.81K |
|
3016
Unity Bancorp
UNTY
$599M
| $364K | ﹤0.01% |
31,480
+408
| +1% | +$5.35K |
|
|
TYME
3017
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $360K | ﹤0.01% |
367,060
+2,992
| +0.8% | +$3.47K |
|
3018
Verrica Pharmaceuticals
VRCA
$87.3M
| $358K | ﹤0.01% |
4,626
+395
| +9% | +$32.4K |
|
3019
Maui Land & Pineapple Co
MLP
$344M
| $357K | ﹤0.01% |
32,979
+172
| +0.5% | +$1.86K |
|
|
CASI
3020
DELISTED
CASI Pharmaceuticals
CASI
| $356K | ﹤0.01% |
23,266
+5,099
| +28% | +$96K |
|
3021
Evolus
EOLS
$501M
| $356K | ﹤0.01% |
91,184
+19,546
| +27% | +$71.4K |
|
3022
Gencor Industries
GENC
$212M
| $348K | ﹤0.01% |
31,532
| – | – |
|
|
STR
3023
DELISTED
Sitio Royalties
STR
| $348K | ﹤0.01% |
35,707
-4,589
| -11% | -$51.6K |
|
|
PHAS
3024
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $347K | ﹤0.01% |
98,702
+66,347
| +205% | +$267K |
|
|
MR
3025
DELISTED
Montage Resources Corporation Common Stock
MR
| $347K | ﹤0.01% |
78,951
+1,944
| +3% | +$8.99K |
|
Similar funds
VFT
Nuveen's Q3 2020 Portfolio in Review
As of Q3 2020, Nuveen held 3,378 positions worth $260B, up 5.8% from $246B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen withdrew a net $9.91B in Q3 2020, closing 90 positions and reducing 1,604 holdings. Its most notable exit was LogMein, Inc., an estimated $32M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Nuveen opened a new position in Pactiv Evergreen Inc. Common stock worth $106M.
- Nuveen's largest Q3 2020 buy was Pactiv Evergreen Inc. Common stock: 8,319,656 shares worth $106M.
- Nuveen added most to JD.com in Q3 2020, an estimated $292M increase.
- Nuveen's biggest Q3 2020 reduction was Amazon, cutting an estimated $1.01B.
- Nuveen fully exited LogMein, Inc. in Q3 2020, selling an estimated $32M.
- Nuveen's ten largest holdings make up 23% of its $260B portfolio in Q3 2020.
- Nuveen opened 92 new positions and closed 90 in Q3 2020.
- Nuveen's portfolio value rose 5.8% quarter-over-quarter to $260B.
Based on Nuveen's 13F filing for Q3 2020, filed 16 Nov 2020.